TGFB1 and synovial sarcoma: To check whether the TGF-β1/Smad pathway affects SS tumor stem cell-like cells, SW982 cells were treated with either 0, 10, or 20 ng/mL rhTGF-β1 and changes in the morphology of the spheroids formed were monitored.